| Roxana Vlad-vonica, MD | |
|
55 Genesee St Bldg 1, Rochester, NY 14611-3201 | |
| (585) 368-3591 | |
| (585) 368-3337 |
| Full Name | Roxana Vlad-vonica |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 30 Years |
| Location | 55 Genesee St Bldg 1, Rochester, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083641815 | NPI | - | NPPES |
| P00391118 | Other | NY | MEDICARE, RAILROAD |
| 02735371 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 251281 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rochester General Hospital | Rochester, NY | Hospital |
| Unity Hospital | Rochester, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rochester General Hospital | 0244149474 | 891 |
| The Unity Hospital Of Rochester | 9436060969 | 517 |
News Archive
A new method of adult stem cell growth, designed in the Area of Cellular Therapy of the University Clinic (University of Navarra), has demonstrated its efficacy for its capacity to grow cornea stem cells.
Mayo Clinic researchers have developed an animal model that can test the function of two prominent tumor suppressor genes, p16 and p19, in the aging process. Scientists knew that both these genes were expressed at increased levels as humans and mice age, but their role in the aging process was not clear. Findings by the Mayo team show that p16 provides gas to accelerate cellular aging, while p19 stops that process.
During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities, pre-existing medication use, demographics and various interventions on disease course.
Interim data from a prospective Investigator Initiated Trial presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by the high-resolution peripheral quantitative computed tomography.
› Verified 4 days ago
| Entity Name | Rochester General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356412712 PECOS PAC ID: 0244149474 Enrollment ID: O20031121000644 |
News Archive
A new method of adult stem cell growth, designed in the Area of Cellular Therapy of the University Clinic (University of Navarra), has demonstrated its efficacy for its capacity to grow cornea stem cells.
Mayo Clinic researchers have developed an animal model that can test the function of two prominent tumor suppressor genes, p16 and p19, in the aging process. Scientists knew that both these genes were expressed at increased levels as humans and mice age, but their role in the aging process was not clear. Findings by the Mayo team show that p16 provides gas to accelerate cellular aging, while p19 stops that process.
During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities, pre-existing medication use, demographics and various interventions on disease course.
Interim data from a prospective Investigator Initiated Trial presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by the high-resolution peripheral quantitative computed tomography.
› Verified 4 days ago
| Entity Name | The Unity Hospital Of Rochester |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760421713 PECOS PAC ID: 9436060969 Enrollment ID: O20031230000038 |
News Archive
A new method of adult stem cell growth, designed in the Area of Cellular Therapy of the University Clinic (University of Navarra), has demonstrated its efficacy for its capacity to grow cornea stem cells.
Mayo Clinic researchers have developed an animal model that can test the function of two prominent tumor suppressor genes, p16 and p19, in the aging process. Scientists knew that both these genes were expressed at increased levels as humans and mice age, but their role in the aging process was not clear. Findings by the Mayo team show that p16 provides gas to accelerate cellular aging, while p19 stops that process.
During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities, pre-existing medication use, demographics and various interventions on disease course.
Interim data from a prospective Investigator Initiated Trial presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by the high-resolution peripheral quantitative computed tomography.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Roxana Vlad-vonica, MD 100 Kings Hwy S, Rochester, NY 14617-5504 Ph: (585) 368-3172 | Roxana Vlad-vonica, MD 55 Genesee St Bldg 1, Rochester, NY 14611-3201 Ph: (585) 368-3591 |
News Archive
A new method of adult stem cell growth, designed in the Area of Cellular Therapy of the University Clinic (University of Navarra), has demonstrated its efficacy for its capacity to grow cornea stem cells.
Mayo Clinic researchers have developed an animal model that can test the function of two prominent tumor suppressor genes, p16 and p19, in the aging process. Scientists knew that both these genes were expressed at increased levels as humans and mice age, but their role in the aging process was not clear. Findings by the Mayo team show that p16 provides gas to accelerate cellular aging, while p19 stops that process.
During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities, pre-existing medication use, demographics and various interventions on disease course.
Interim data from a prospective Investigator Initiated Trial presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by the high-resolution peripheral quantitative computed tomography.
› Verified 4 days ago
Amy Bodrog, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4020 Fax: 585-922-4622 | |
Natalia Golub, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 30 Hagen Dr Ste 320, Rochester, NY 14625 Phone: 585-922-1900 | |
Hanan Ibrahim Sheikh Ibrahim, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1415 Portland Ave Ste 200, Rochester, NY 14621 Phone: 585-922-0390 Fax: 585-922-0395 | |
Numra Aslam Bajwa, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 Fax: 716-862-1871 | |
Dr. Prakash Upreti, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 295-029-8769 | |
William M Valenti, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 259 Monroe Avenue, Rochester, NY 14607 Phone: 585-545-7200 Fax: 585-244-6456 | |
Ms. Terri Winter, N.P. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 250 Crittenden Blvd, Box 617, Rochester, NY 14642 Phone: 585-275-2662 Fax: 585-276-0149 |